Bioavailabilitas dan Admet

The understanding of ADME-T (Absorption, Distribution, Metabolism, Excretion, and Toxicity) parameters is essential in modern pharmacokinetic studies and rational drug design. Absorption determines how effectively a compound crosses biological membranes to reach systemic circulation, while distribution describes how it spreads throughout body tissues depending on plasma protein binding and membrane permeability. Metabolism, mainly occurring in the liver, transforms lipophilic compounds into hydrophilic metabolites to facilitate their elimination, and excretion represents the removal of these substances through urine, bile, or sweat. Toxicity assessment ensures that the compound does not cause harmful effects on vital organs such as the liver, kidneys, or central nervous system. In recent years, computational chemistry and in silico prediction tools have revolutionized drug discovery by enabling early evaluation of pharmacokinetic and toxicity properties. Web-based platforms like SwissADME, pkCSM, ADMETlab, admetSAR, and Molinspiration allow researchers to predict absorption, bioavailability, permeability, and drug-likeness, reducing experimental costs and time. The integration of these computational approaches with experimental validation enhances the efficiency of drug development, ensuring that selected compounds possess balanced pharmacological efficacy, safety, and bioavailability. Overall, the application of ADME-T modeling represents a crucial step toward optimizing the pharmacokinetic profile and minimizing the toxicity risks of potential drug candidates.